HYPIEND partners from KU Leuven have presented the project’s use of organoid models at the “3D Organ modelling in Health and Disease 2024” international symposium that took place in Leuven, Belgium, on the 8th and 9th of April 2024.
The event is the inaugural symposium of the new networking platform organoid@KUL dedicated to 3D organ bioengineering. For two days, it brought together researchers, clinicians, and industry stakeholders to present cutting-edge expertise and breakthroughs in this field.
Professor Hugo Vankelecom from KU Leuven and HYPIEND partner presented on 9 April their studies entitled “Organoid models to explore human reproductive biology in health and disease” and, among others, showed the HYPIEND’s approach.
KU Leuven will contribute to HYPIEND delivering beyond state-of-the-art organoid/organ-on-chip (OoC) models of the endocrine axis to study the impact of EDCs. Furthermore, KU Leuven will run a multinational trial to evaluate the effectiveness of a behavioral intervention to reduce the levels of EDC in pregnant and breastfeeding women, as well as in their offspring up to 18 months after birth.
